SR One

About SR One

SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. They adopt a back-and-build approach to investments, focusing on companies with strong fundamentals, clear development pathways, and novel approaches to addressing diseases, aiming to reimagine today's science for tomorrow's medicines.

Products & Services

Venture Capital Investments:SR One invests in biotechnology companies with a focus on translating science into medicines, supporting portfolio companies with strategic partnerships and regional expertise.

Portfolio Companies:SR One supports a range of biotech firms including Dren Bio, Tranquis Therapeutics, Avenzo Therapeutics, Ancora Biotech, Arcellx, Palleon Pharmaceuticals, Adarx Pharmaceuticals, Mineralys Therapeutics, Xap Therapeutics, CRISPR Therapeutics, Econic Biosciences, Design Therapeutics, Simcha Therapeutics, and Nimbus.

Specialties

Venture Capital Biotech Innovation Transatlantic Investment Science to Medicine Translation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Fund T: - FT: Venture Fund	A: 600000000 MR: - FA: $600 million FAN: 600000000	D: 2023-03-27 FD: 2023-03-27	6 investors

Venture Fund Latest

2023-03-27

$600.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Simeon George

CEO & Managing Partner

LinkedIn (Pro only)

R

Rajeev Dadoo, PhD

COO & Managing Partner

LinkedIn (Pro only)

J

Jill Carroll

Partner

J

Jake Nunn

Partner

P

Philip Habib

Head of Capital Partnering

S

Sasha Keough

General Counsel & Chief Compliance Officer

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

SR One Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised